These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30906878)

  • 21. Outcome measurements in scleroderma: results from a delphi exercise.
    Gazi H; Pope JE; Clements P; Medsger TA; Martin RW; Merkel PA; Kahaleh B; Wollheim FA; Baron M; Csuka ME; Emery P; Belch JF; Hayat S; Lally EV; Korn JH; Czirjak L; Herrick A; Voskuyl AE; Bruehlmann P; Inanc M; Furst DE; Black C; Ellman MH; Moreland LW; Rothfield NF; Hsu V; Mayes M; McKown KM; Krieg T; Siebold JR
    J Rheumatol; 2007 Mar; 34(3):501-9. PubMed ID: 17299843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose naltrexone for pruritus in systemic sclerosis.
    Frech T; Novak K; Revelo MP; Murtaugh M; Markewitz B; Hatton N; Scholand MB; Frech E; Markewitz D; Sawitzke AD
    Int J Rheumatol; 2011; 2011():804296. PubMed ID: 21918649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
    Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
    Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
    Kowal-Bielecka O; Landewé R; Avouac J; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M;
    Ann Rheum Dis; 2009 May; 68(5):620-8. PubMed ID: 19147617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and correlates of sleep disturbance in systemic sclerosis--results from the UCLA scleroderma quality of life study.
    Frech T; Hays RD; Maranian P; Clements PJ; Furst DE; Khanna D
    Rheumatology (Oxford); 2011 Jul; 50(7):1280-7. PubMed ID: 21324979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The assessment of malnutrition and severity of gastrointestinal disease by using symptom-based questionnaires in systemic sclerosis: is it related to severe organ involvement or capillary rarefaction at microcirculation?
    Yalcinkaya Y; Erturk Z; Unal AU; Kaymaz Tahra S; Pehlivan O; Atagunduz P; Direskeneli H; Inanç N
    Clin Exp Rheumatol; 2020; 38 Suppl 125(3):127-131. PubMed ID: 32141434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality indicator set for systemic sclerosis.
    Khanna D; Kowal-Bielecka O; Khanna PP; Lapinska A; Asch SM; Wenger N; Brown KK; Clements PJ; Getzug T; Mayes MD; Medsger TA; Oudiz R; Simms R; Steen V; Maranian P; Furst DE
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S33-9. PubMed ID: 21586216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic review of systemic sclerosis-specific instruments for the EULAR Outcome Measures Library: An evolutional database model of validated patient-reported outcomes.
    Ingegnoli F; Carmona L; Castrejon I
    Semin Arthritis Rheum; 2017 Apr; 46(5):609-614. PubMed ID: 27839740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature.
    Giuggioli D; Lumetti F; Colaci M; Fallahi P; Antonelli A; Ferri C
    Autoimmun Rev; 2015 Nov; 14(11):1072-8. PubMed ID: 26209905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic sclerosis. A clinical overview.
    Generini S; Fiori G; Moggi Pignone A; Matucci Cerinic M; Cagnoni M
    Adv Exp Med Biol; 1999; 455():73-83. PubMed ID: 10599326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations between the Composite Response Index in Diffuse Cutaneous Systemic Sclerosis (CRISS), survival and other disease measures.
    Zheng B; Wang M; Stevens W; Proudman S; Nikpour M; Baron M; ;
    Semin Arthritis Rheum; 2022 Apr; 53():151973. PubMed ID: 35149318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Support Groups in Scleroderma.
    Rice DB; Thombs BD
    Curr Rheumatol Rep; 2019 Feb; 21(4):9. PubMed ID: 30790067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probiotics for the treatment of systemic sclerosis-associated gastrointestinal bloating/ distention.
    Frech TM; Khanna D; Maranian P; Frech EJ; Sawitzke AD; Murtaugh MA
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S22-5. PubMed ID: 21586214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis.
    Zampatti N; Garaiman A; Jordan S; Dobrota R; Becker MO; Maurer B; Distler O; Mihai C
    Arthritis Res Ther; 2021 Apr; 23(1):125. PubMed ID: 33888149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment Algorithms for Systemic Sclerosis According to Experts.
    Fernández-Codina A; Walker KM; Pope JE;
    Arthritis Rheumatol; 2018 Nov; 70(11):1820-1828. PubMed ID: 29781586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation and management of gastrointestinal manifestations in scleroderma.
    Kirby DF; Chatterjee S
    Curr Opin Rheumatol; 2014 Nov; 26(6):621-9. PubMed ID: 25207461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correction:
    Ann Rheum Dis; 2019 Aug; 78(8):e88. PubMed ID: 31296652
    [No Abstract]   [Full Text] [Related]  

  • 39. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Change in calcinosis over 1 year using the scleroderma clinical trials consortium radiologic scoring system for calcinosis of the hands in patients with systemic sclerosis.
    Valenzuela A; Stevens K; Chung MP; Rodriguez-Reyna TS; Proudman S; Baron M; Castelino FV; Hsu V; Green L; Galdo FD; Li S; Fiorentino D; Chung L
    Semin Arthritis Rheum; 2022 Apr; 53():151980. PubMed ID: 35183935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.